Does Humana Cover Weight Loss Treatment in Mississippi? A 2026 Guide

Last updated: July 11, 2026

If you have Humana Medicare Advantage coverage in Mississippi and you are looking for help with weight management, your path to coverage may be different from what you expect. Medicare Part D — which covers most prescription drugs — has historically excluded weight loss medications. However, a landmark federal program launched on July 1, 2026 has changed that for many Medicare Advantage members. This guide explains your coverage options, how the Medicare GLP-1 Bridge works, and how Klarity Health can connect you with a licensed Mississippi provider to discuss your treatment plan.

Disclaimer: Coverage varies by plan year, employer group, and individual benefit design. All information in this guide is for educational purposes only. Verify your specific benefits by calling Humana Member Services before booking an appointment.

Ready to explore weight loss treatment options? Klarity Health connects Mississippi residents with licensed providers who can evaluate your eligibility, submit prior authorization requests, and manage GLP-1 prescriptions. See if you may qualify for weight loss treatment →

The Medicare GLP-1 Bridge: The Primary Coverage Pathway for Humana MA Members (2026)

Effective July 1, 2026, eligible Humana Medicare Advantage Prescription Drug (MAPD) plan members may access Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (a new GLP-1 entrant) at a $50 per month cost-share under a CMS-administered program. This is the Medicare GLP-1 Bridge.

Key facts about the Bridge:

• Administered by CMS directly — not through HPS (Humana Pharmacy Solutions), Humana’s standard PBM. The Bridge runs outside the standard Part D formulary.
• Covered medications: Wegovy (semaglutide 2.4 mg injectable), Zepbound (tirzepatide injectable), Foundayo.
• Member cost-share: $50 per month per covered medication.
• Eligibility criteria: Must be enrolled in a Humana MAPD plan; must have a diagnosis of obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity (e.g., type 2 diabetes, hypertension, hyperlipidemia, sleep apnea, cardiovascular disease).
• Prior authorization may still apply at the plan level to confirm eligibility criteria.
• This is not a standard formulary benefit — it will not appear on the standard HPS Part D formulary lookup tool. Members should ask Humana specifically about the CMS GLP-1 Bridge when calling.

Before July 1, 2026, Medicare Part D plans — including Humana MAPD plans — were prohibited by federal law from covering weight loss drugs. The Bridge program represents the first time Medicare has covered GLP-1 medications for weight management at scale. If you had a prior authorization denial for Wegovy or Zepbound under your Humana MA plan before this date, you may now be eligible to reapply under the Bridge program.

To confirm Bridge eligibility and initiate coverage, call Humana Member Services at 1-800-448-6262 or CMS directly at 1-800-633-4227.

Does Humana Cover Weight Loss in Mississippi? Plan Context

Humana exited the commercial insurance market in Mississippi in 2024. As of 2026, Humana only offers Medicare Advantage plans in Mississippi — not individual, employer, or ACA marketplace plans. If you have a Humana plan in Mississippi, you are on a Medicare Advantage plan.

Humana’s Medicare Advantage plans in Mississippi include:

• Humana Gold Plus HMO
• HumanaChoice PPO
• Humana Honor HMO-POS
• Humana Regional/Hybrid PPO (R/H PPO)

All of these are MAPD plans — meaning they include Medicare Part D prescription drug coverage administered through Humana Pharmacy Solutions (HPS). Prescription drug coverage follows the HPS formulary for most medications, with the Medicare GLP-1 Bridge as the exception for approved weight loss medications.

HPS Standard Part D Formulary: Weight Management Medications

Outside the Medicare GLP-1 Bridge, the HPS Part D formulary covers a limited range of weight management medications. Older, lower-cost agents are generally covered at lower tiers; newer GLP-1 medications were historically not covered under Part D and are now accessible primarily through the Bridge program.

Tier placements are approximate. Your specific plan year benefits determine your exact cost-share. Verify current formulary at humana.com or by calling 1-800-448-6262.

Does EPCS Apply to Weight Loss Medications?

Mississippi’s Electronic Prescribing for Controlled Substances (EPCS) requirement under Miss. Code Ann. § 456.44 applies exclusively to Schedule II controlled substances. It does not apply to Schedule IV or non-scheduled medications.

• Phentermine and Qsymia: Schedule IV — EPCS does not apply.
• GLP-1 medications (Wegovy, Zepbound, Saxenda, Foundayo): Non-scheduled — EPCS does not apply.
• Contrave (naltrexone/bupropion) and orlistat: Non-scheduled — EPCS does not apply.

No weight loss medication currently in common clinical use is a Schedule II substance. Klarity Health providers can prescribe all covered weight loss medications electronically without Schedule II EPCS requirements.

Mental Health Parity and Weight Loss Coverage

The federal Mental Health Parity and Addiction Equity Act (MHPAEA), as applied to Medicare Advantage plans under CMS 42 CFR Part 422, requires that mental health and substance use disorder benefits be no more restrictive than comparable medical/surgical benefits. This federal parity law governs all Humana Medicare Advantage plans in Mississippi.

Note: Mississippi’s state parity statute, Miss. Code Ann. § 83-9-353 et seq., applies to commercial insurance plans — it does not apply to Medicare Advantage plans, which are governed by federal law. The practical effect is equivalent, but patients on Humana MA plans should reference their federal rights, not state statute, when filing parity complaints.

Weight loss coverage and parity: Parity law governs mental health and substance use benefits. Weight loss medications are not directly covered by mental health parity mandates. Coverage of weight loss medications under Humana MA plans is primarily determined by: (1) the Medicare GLP-1 Bridge program (CMS-administered), and (2) the HPS Part D formulary for older agents. Employers and individual plan designs drive whether benefits beyond these exist.

Medicaid and Dual-Eligible Members

Humana’s Mississippi presence is limited to Medicare Advantage. Humana does not administer Medicaid managed care plans in Mississippi. If you are a dual-eligible (Medicare + Medicaid) beneficiary, you may be enrolled in a Dual Eligible Special Needs Plan (D-SNP) through Humana. D-SNP plans may have additional weight management benefits — verify with Humana by calling 1-800-448-6262.

Mississippi Medicaid (Envision Healthcare-administered) and the Mississippi Division of Medicaid (DOM) manage Medicaid benefits separately. If you are unsure which coverage applies to you, contact the Mississippi Division of Insurance at 1-800-562-2957.

Prior Authorization Process for Weight Loss Medications

Even under the Medicare GLP-1 Bridge, clinical criteria must typically be met before coverage is confirmed. The standard prior authorization (PA) process for Humana MAPD weight loss medications generally requires:

1. Diagnosis documentation: BMI ≥30, or BMI ≥27 with at least one documented comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease).
2. Lifestyle intervention documentation: Evidence of participation in a structured weight management program (dietary counseling, behavioral program, or provider-supervised lifestyle modification).
3. Step therapy (for some agents): Trial of a lower-tier agent (e.g., orlistat or phentermine) may be required before GLP-1 approval, depending on the specific plan and benefit design.
4. Annual re-authorization: Ongoing coverage of GLP-1 medications typically requires annual re-authorization with documentation of continued clinical response (typically ≥5% weight loss from baseline).

Medicare Part D PA timelines under 42 CFR Part 423 are: 72 hours for standard requests and 24 hours for urgent requests. Members have five levels of appeal rights: redetermination, reconsideration, ALJ hearing, Medicare Appeals Council, and federal court review.

Klarity Health providers are experienced in documenting clinical criteria and submitting PA requests through Humana’s prior authorization portal. Approval is not guaranteed and coverage varies by plan year and benefit design.

Weight Loss Treatment with Klarity Health in Mississippi

Klarity Health offers telehealth weight management consultations with licensed providers in Mississippi. Our network includes 2,000+ licensed providers across specialties. During your visit, a provider can:

• Evaluate your BMI, comorbidities, and medical history
• Discuss GLP-1 medication options (Wegovy, Zepbound, Saxenda) and whether you may be eligible under the Medicare GLP-1 Bridge
• Prescribe covered weight management medications if clinically appropriate
• Submit prior authorization requests to Humana on your behalf
• Monitor your progress and manage dosage titration

Telehealth visits for weight management are reimbursable under Medicare Advantage plans, including Humana MAPD plans, under CMS telehealth parity rules extended post-2025.

Check if you may qualify for weight loss treatment through Klarity Health. Our Mississippi-licensed providers can evaluate your eligibility for GLP-1 medications and help navigate Humana MA coverage. See if you may qualify →

Frequently Asked Questions

Does Humana Medicare Advantage cover Wegovy or Zepbound in Mississippi?

As of July 1, 2026, eligible Humana MAPD members may access Wegovy and Zepbound at $50 per month through the CMS Medicare GLP-1 Bridge program. This is separate from the standard HPS Part D formulary, which historically did not cover weight loss medications. Call Humana Member Services at 1-800-448-6262 to verify your plan’s eligibility for the Bridge program.

What is the Medicare GLP-1 Bridge and how do I access it?

The Medicare GLP-1 Bridge is a CMS-administered program effective July 1, 2026 that provides eligible MAPD members with access to Wegovy, Zepbound, and Foundayo at a $50/month cost-share. It is processed outside the standard Part D formulary. To access it, your provider must submit documentation of your diagnosis and clinical eligibility. A Klarity Health provider can help initiate this process.

Does EPCS apply to weight loss prescriptions under Humana in Mississippi?

No. Mississippi’s EPCS requirement applies only to Schedule II controlled substances. No commonly prescribed weight loss medication — including phentermine (Schedule IV), GLP-1 medications (non-scheduled), Contrave (non-scheduled), or orlistat (non-scheduled) — is a Schedule II substance. EPCS requirements do not affect weight loss prescriptions.

What if Humana denies my weight loss medication prior authorization?

Under Medicare Part D appeal rights, you have five levels of appeal: (1) redetermination by Humana, (2) reconsideration by an independent review entity, (3) ALJ hearing, (4) Medicare Appeals Council review, and (5) federal court. Standard redetermination decisions are issued within 7 days; expedited decisions within 72 hours. Your Klarity Health provider can provide supporting clinical documentation to strengthen an appeal.

Can I get weight loss treatment through Klarity Health if I have Humana Medicare Advantage in Mississippi?

Yes. Klarity Health offers telehealth weight management consultations with licensed Mississippi providers. Telehealth visits are generally covered by Humana MAPD plans under CMS telehealth rules. Coverage of specific medications and prior authorization outcomes vary by plan and clinical criteria — verify your benefits before booking. See if you may qualify →

Contact Information

• Humana Member Services: 1-800-448-6262 (TTY: 711)
• Humana Medicare Advantage Customer Care: 1-800-379-0092
• Humana Pharmacy (HPS): 1-877-693-5236
• CMS Medicare Helpline (Bridge Program): 1-800-633-4227
• Mississippi Department of Insurance: 1-800-562-2957

Start your weight loss consultation today. Klarity Health’s Mississippi-licensed providers can discuss GLP-1 options, the Medicare GLP-1 Bridge program, and medication eligibility — all via telehealth. See if you may qualify for weight loss treatment →

Disclaimer: This content is for informational purposes only and does not constitute medical or legal advice. Insurance coverage for weight loss treatment varies by plan, plan year, and individual benefit design. Medicare GLP-1 Bridge eligibility is subject to CMS criteria and individual plan confirmation. Klarity Health does not guarantee coverage or prior authorization approval. Patients should verify their specific benefits with Humana before scheduling an appointment. Klarity Health providers are licensed in Mississippi and operate within applicable state and federal telehealth regulations.